BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26209885)

  • 1. Emerging roles for IL-11 signaling in cancer development and progression: Focus on breast cancer.
    Johnstone CN; Chand A; Putoczki TL; Ernst M
    Cytokine Growth Factor Rev; 2015 Oct; 26(5):489-98. PubMed ID: 26209885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer.
    Putoczki T; Ernst M
    J Leukoc Biol; 2010 Dec; 88(6):1109-17. PubMed ID: 20610798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-11 signaling as a therapeutic target for cancer.
    Putoczki TL; Ernst M
    Immunotherapy; 2015; 7(4):441-53. PubMed ID: 25917632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathways: IL11 as a tumor-promoting cytokine-translational implications for cancers.
    Ernst M; Putoczki TL
    Clin Cancer Res; 2014 Nov; 20(22):5579-88. PubMed ID: 25074610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130.
    Howlett M; Judd LM; Jenkins B; La Gruta NL; Grail D; Ernst M; Giraud AS
    Gastroenterology; 2005 Sep; 129(3):1005-18. PubMed ID: 16143138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically.
    Putoczki TL; Thiem S; Loving A; Busuttil RA; Wilson NJ; Ziegler PK; Nguyen PM; Preaudet A; Farid R; Edwards KM; Boglev Y; Luwor RB; Jarnicki A; Horst D; Boussioutas A; Heath JK; Sieber OM; Pleines I; Kile BT; Nash A; Greten FR; McKenzie BS; Ernst M
    Cancer Cell; 2013 Aug; 24(2):257-71. PubMed ID: 23948300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma.
    Campbell CL; Jiang Z; Savarese DM; Savarese TM
    Am J Pathol; 2001 Jan; 158(1):25-32. PubMed ID: 11141475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy.
    Selander KS; Li L; Watson L; Merrell M; Dahmen H; Heinrich PC; Müller-Newen G; Harris KW
    Cancer Res; 2004 Oct; 64(19):6924-33. PubMed ID: 15466183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial gp130/Stat3 functions: an intestinal signaling node in health and disease.
    Ernst M; Thiem S; Nguyen PM; Eissmann M; Putoczki TL
    Semin Immunol; 2014 Feb; 26(1):29-37. PubMed ID: 24434062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-6 signal transduction and its physiological roles: the signal orchestration model.
    Kamimura D; Ishihara K; Hirano T
    Rev Physiol Biochem Pharmacol; 2003; 149():1-38. PubMed ID: 12687404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of interleukin-6, interleukin-6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma.
    Karczewska A; Nawrocki S; Breborowicz D; Filas V; Mackiewicz A
    Cancer; 2000 May; 88(9):2061-71. PubMed ID: 10813718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 and interleukin-11: same same but different.
    Garbers C; Scheller J
    Biol Chem; 2013 Sep; 394(9):1145-61. PubMed ID: 23740659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification.
    Chen CC; Chu CB; Liu KJ; Huang CY; Chang JY; Pan WY; Chen HH; Cheng YH; Lee KD; Chen MF; Kuo CC; Chen LT
    Biochem Pharmacol; 2013 Oct; 86(7):872-87. PubMed ID: 23933386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of gp130/interleukin-6 receptor transducing component in interleukin-11 receptor.
    Fourcin M; Chevalier S; Lebrun JJ; Kelly P; Pouplard A; Wijdenes J; Gascan H
    Eur J Immunol; 1994 Jan; 24(1):277-80. PubMed ID: 8020567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
    Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
    Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Understanding of Interleukin 6 Family Cytokine Signaling and Targeted Therapies: Focus on Interleukin 11.
    Metcalfe RD; Putoczki TL; Griffin MDW
    Front Immunol; 2020; 11():1424. PubMed ID: 32765502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interleukin-6 family cytokine interleukin-11 regulates homeostatic epithelial cell turnover and promotes gastric tumor development.
    Howlett M; Giraud AS; Lescesen H; Jackson CB; Kalantzis A; Van Driel IR; Robb L; Van der Hoek M; Ernst M; Minamoto T; Boussioutas A; Oshima H; Oshima M; Judd LM
    Gastroenterology; 2009 Mar; 136(3):967-77. PubMed ID: 19121317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13.
    Gingras S; Moriggl R; Groner B; Simard J
    Mol Endocrinol; 1999 Jan; 13(1):66-81. PubMed ID: 9892013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-11 increases invasiveness of JEG-3 choriocarcinoma cells by modulating STAT3 expression.
    Suman P; Poehlmann TG; Prakash GJ; Markert UR; Gupta SK
    J Reprod Immunol; 2009 Oct; 82(1):1-11. PubMed ID: 19716605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.